Track topics on Twitter Track topics that are important to you
Abbott's new glucose monitoring device could be used by millions of diabetes patients in the US after government-funded health schemes agreed to pay for it. The medical devices specialist said that the Centers for Medicare and Medicaid Services (C...
Original Article: Medicare to fund Abbott's needle-free diabetes monitorNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...